Skip to content
TriangleGet started
← Full study record

NCT01558921 · OUTCOME

Number of Patients Completing the Prescribe Neo-adjuvant Treatment Dose

Rectal Cancer And Pre-operative Induction Therapy Followed by Dedicated Operation. The RAPIDO Trial · Source last updated 2026-05-01

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
30 days after neoadjuvant treatment

What was measured

Number of patients in the experimental arm receiving 5 fractions of x 5 Gy (5x5Gy) radiotherapy followed by at least 75% of the prescribed chemotherapy. In the standard arm receiving the prescribed chemoradiotherapy.

Analysis population: 901 of the 920 patients were evaluable

Groups in this outcome

B: 5x5Gy -> CAPOX -> Surgery

Experimental group B: 5x5Gy -\> CAPOX -\> Surgery

A: 5 Weeks Chemoradiation -> Surgery

Control group A: 5 Weeks Chemoradiation -\> Surgery

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
B: 5x5Gy -> CAPOX -> Surgery460
A: 5 Weeks Chemoradiation -> Surgery441

Reported measurements

Source class 1

received at least 75% of the prescribed chemotherapy

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
B: 5x5Gy -> CAPOX -> Surgery386Not reportedNot reportedNot reportedNot reported
A: 5 Weeks Chemoradiation -> Surgery410Not reportedNot reportedNot reportedNot reported

received less than 75 % of the prescribed neoadjuvant treatment

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
B: 5x5Gy -> CAPOX -> Surgery74Not reportedNot reportedNot reportedNot reported
A: 5 Weeks Chemoradiation -> Surgery31Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        386
      2. group Id
        OG001
        value
        410
      title
      received at least 75% of the prescribed chemotherapy
    2. measurements
      1. group Id
        OG000
        value
        74
      2. group Id
        OG001
        value
        31
      title
      received less than 75 % of the prescribed neoadjuvant treatment
denoms
  1. counts
    1. group Id
      OG000
      value
      460
    2. group Id
      OG001
      value
      441
    units
    Participants
description
Number of patients in the experimental arm receiving 5 fractions of x 5 Gy (5x5Gy) radiotherapy followed by at least 75% of the prescribed chemotherapy. In the standard arm receiving the prescribed chemoradiotherapy.
groups
  1. description
    Experimental group B: 5x5Gy -\> CAPOX -\> Surgery
    id
    OG000
    title
    B: 5x5Gy -> CAPOX -> Surgery
  2. description
    Control group A: 5 Weeks Chemoradiation -\> Surgery
    id
    OG001
    title
    A: 5 Weeks Chemoradiation -> Surgery
param Type
COUNT_OF_PARTICIPANTS
population Description
901 of the 920 patients were evaluable
reporting Status
POSTED
time Frame
30 days after neoadjuvant treatment
title
Number of Patients Completing the Prescribe Neo-adjuvant Treatment Dose
type
SECONDARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-191f4516d4760045304b24a0

Preserved source evidence · Independent clinical review pending · Not medical advice